SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-051229
Filing Date
2024-04-24
Accepted
2024-04-24 16:18:36
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-24

Document Format Files

Seq Description Document Type Size
1 ARS tm2412576d2_ars.pdf ARS 3833423
  Complete submission text file 0001104659-24-051229.txt   5260185
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41740 | Film No.: 24870837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)